Achievable logoAchievable logo
USMLE/1
Sign in
Sign up
Purchase
Textbook
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Anatomy
2. Microbiology
3. Physiology
4. Pathology
4.1 General pathology
4.2 Central and peripheral nervous system
4.3 Cardiovascular system
4.4 Respiratory system
4.5 Hematology and oncology
4.6 Gastrointestinal pathology
4.6.1 Salivary gland pathology
4.6.2 Esophageal disorders
4.6.3 Diverticula of the esophagus
4.6.4 Stomach
4.6.5 Small intestine
4.6.6 Mesenteric ischemia
4.6.7 Large intestine
4.6.8 Ischemic colitis
4.6.9 Benign and malignant growths of the colon
4.6.10 Rectum and anal canal
4.6.11 Disorders of the liver
4.6.12 Cirrhosis and portal hypertension (PHT)
4.6.13 Benign masses in the liver
4.6.14 Disorders of the gallbladder and bile ducts
4.6.15 Cholangitis
4.6.16 Cholangiocarcinoma
4.6.17 Disorders of the pancreas
4.6.18 Additional information
4.7 Renal, endocrine and reproductive system
4.8 Musculoskeletal system
5. Pharmacology
6. Immunology
7. Biochemistry
8. Cell and molecular biology
9. Biostatistics and epidemiology
10. Genetics
11. Behavioral science
Wrapping up
Achievable logoAchievable logo
4.6.15 Cholangitis
Achievable USMLE/1
4. Pathology
4.6. Gastrointestinal pathology

Cholangitis

2 min read
Font
Discuss
Share
Feedback

Primary biliary cirrhosis or primary biliary cholangitis: This is an autoimmune, chronic, progressive disorder that is more common in women. It is characterized by inflammation and scarring of the intrahepatic bile ducts. It typically presents with jaundice, pruritus, abdominal pain, and fatigue. Complications include portal hypertension, fat-soluble vitamin deficiencies, osteoporosis, and cirrhosis. Other autoimmune disorders may be associated.

Hypercholesterolemia can occur due to biliary stasis. Most patients are positive for antimitochondrial antibodies, such as PDC-E2 (pyruvate dehydrogenase). A past bacterial or viral infection can act as a trigger.

Diagnosis is based on:

  • Elevated direct bilirubin, alkaline phosphatase, GGT, AST, and ALT
  • Positive antimitochondrial antibodies
  • MRI findings, including a periportal halo sign, lymphadenopathy, and increased signal intensities in the liver

Treatment includes ursodeoxycholic acid or obeticholic acid, cholestyramine for pruritus, fibrates, and liver transplant.

Primary biliary cirrhosis with halo sign
Primary biliary cirrhosis with halo sign

Primary sclerosing cholangitis (PSC): This disorder is characterized by inflammation and scarring (sclerosis) of the bile ducts, involving both intrahepatic and extrahepatic bile ducts. It is more common in men. It can present with fatigue, pruritus, jaundice, and splenomegaly. It can also lead to fat-soluble vitamin deficiencies, osteoporosis, cirrhosis, and liver failure.

About 70% of patients with PSC have IBD, most commonly ulcerative colitis. PSC has also been associated with autoimmune disorders such as type 1 diabetes mellitus, celiac disease, RA, and Grave’s disease. It is strongly associated with HLA A1, B8, DR6, and DR3. There is an increased risk of choledocholithiasis and cholangiocarcinoma.

Laboratory findings include elevated AST, ALT, alkaline phosphatase, gamma glutamyl transpeptidase, gamma globulins (raised IgM), and elevated direct bilirubin. pANCA, anti-smooth muscle antibodies, ANA, and anticardiolipin antibodies may be positive.

Imaging studies include MRCP, ERCP, and PTC (percutaneous transhepatic cholangiography). Imaging shows multiple strictures and dilations, producing a beaded appearance. Biopsy shows characteristic onion-skin (concentric) fibrosis.

Treatment includes cholestyramine for pruritus, ursodeoxycholic acid, endoscopic balloon dilation of bile ducts, supportive therapy, and definitive treatment with liver transplantation.

Sign up for free to take 1 quiz question on this topic

All rights reserved ©2016 - 2026 Achievable, Inc.